- ICD18108K ;ALB/JDG - YEARLY DRG UPDATE; October 01, 2020@15:42
- ;;18.0;DRG Grouper;**108**;October 20, 2000;Build 3
- ;
- ; Updates for DRGS 810-999
- Q
- ;
- MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
- ;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^0.9617^2.5
- ;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.3793^3.6
- ;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.8803^2.7
- ;;813^16^MED^COAGULATION DISORDERS^1.5451^3.6
- ;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^1.8917^4.5
- ;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^0.9934^2.9
- ;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.6611^2.2
- ;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^2.3068^4.1
- ;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^1.3598^3.0
- ;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.9872^1.7
- ;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^5.6917^10.6
- ;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.1552^3.7
- ;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.2515^1.8
- ;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.5018^10.3
- ;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.3644^5.3
- ;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.4015^2.4
- ;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^5.0445^9.9
- ;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.5006^4.9
- ;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.6740^2.8
- ;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.2084^6.2
- ;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.4820^2.3
- ;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.1218^3.4
- ;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7783^2.5
- ;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5370^1.9
- ;;834^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC^6.0522^10.0
- ;;835^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC^2.1137^4.2
- ;;836^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.1735^2.7
- ;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^5.6993^11.5
- ;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^2.2602^5.5
- ;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.4872^4.4
- ;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.2205^6.7
- ;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.6216^4.0
- ;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.0970^2.8
- ;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.9076^5.3
- ;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.1842^3.6
- ;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8489^2.6
- ;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.6729^5.9
- ;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.3361^3.6
- ;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.0323^3.0
- ;;849^17^MED^RADIOTHERAPY^2.4936^6.2
- ;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^4.9678^9.6
- ;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^2.1222^5.3
- ;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.5198^3.3
- ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.6639^9.2
- ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1024^5.4
- ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.3596^3.5
- ;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.8967^5.0
- ;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^1.0114^3.5
- ;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8765^2.7
- ;;865^18^MED^VIRAL ILLNESS WITH MCC^1.4778^3.9
- ;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.8390^2.7
- ;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.2371^5.5
- ;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.0660^3.5
- ;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.7285^2.5
- ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.4390^12.4
- ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.8722^4.8
- ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.0263^3.5
- ;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.2680^7.0
- ;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.8645^2.6
- ;;881^19^MED^DEPRESSIVE NEUROSES^0.8020^3.9
- ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.8236^3.2
- ;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.5818^5.1
- ;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.4473^4.5
- ;;885^19^MED^PSYCHOSES^1.2394^5.9
- ;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^1.2237^4.3
- ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0798^3.0
- ;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5490^2.0
- ;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.5992^8.9
- ;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7803^4.9
- ;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8270^3.4
- ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.2687^8.8
- ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.9643^4.8
- ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.1353^2.6
- ;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.7270^7.1
- ;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.6500^3.3
- ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.8038^2.8
- ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.9482^6.8
- ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^2.0504^3.9
- ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.3710^2.4
- ;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.6386^3.7
- ;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.8869^2.5
- ;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.6995^3.7
- ;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.6584^1.8
- ;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.4785^3.5
- ;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.7916^2.3
- ;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.8441^4.3
- ;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0246^2.9
- ;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.6979^2.1
- ;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.5882^4.1
- ;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^0.9398^2.7
- ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^21.0913^26.0
- ;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^6.5316^11.7
- ;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^3.0139^5.9
- ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^2.2629^2.4
- ;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^1.9409^4.3
- ;;935^22^MED^NON-EXTENSIVE BURNS^1.9329^3.6
- ;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.3746^6.6
- ;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.2209^3.5
- ;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^1.9231^2.2
- ;;945^23^MED^REHABILITATION WITH CC/MCC^1.4819^5.0
- ;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.1262^3.2
- ;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.1940^3.5
- ;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.7871^2.6
- ;;949^23^MED^AFTERCARE WITH CC/MCC^1.1099^4.3
- ;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.7402^3.0
- ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.5596^1.8
- ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.2893^7.3
- ;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.8500^6.0
- ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.4209^9.1
- ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.2057^6.7
- ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.7361^4.2
- ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7299^5.2
- ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.4918^3.9
- ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9125^2.6
- ;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^5.8519^11.1
- ;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^2.9887^6.6
- ;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.6905^6.3
- ;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.2821^4.0
- ;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^0.9496^3.0
- ;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.3243^3.6
- ;;981^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.6145^8.4
- ;;982^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.5366^4.6
- ;;983^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.6523^2.3
- ;;987^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.2759^7.7
- ;;988^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.7064^4.3
- ;;989^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.1236^2.3
- ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0^0.0
- ;;999^99^**^UNGROUPABLE^0.0^0.0
- ;;EXIT
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD18108K 10668 printed Mar 13, 2025@20:52:36 Page 2
- ICD18108K ;ALB/JDG - YEARLY DRG UPDATE; October 01, 2020@15:42
- +1 ;;18.0;DRG Grouper;**108**;October 20, 2000;Build 3
- +2 ;
- +3 ; Updates for DRGS 810-999
- +4 QUIT
- +5 ;
- MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
- +1 ;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^0.9617^2.5
- +2 ;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.3793^3.6
- +3 ;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.8803^2.7
- +4 ;;813^16^MED^COAGULATION DISORDERS^1.5451^3.6
- +5 ;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^1.8917^4.5
- +6 ;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^0.9934^2.9
- +7 ;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.6611^2.2
- +8 ;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^2.3068^4.1
- +9 ;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^1.3598^3.0
- +10 ;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.9872^1.7
- +11 ;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^5.6917^10.6
- +12 ;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.1552^3.7
- +13 ;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.2515^1.8
- +14 ;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.5018^10.3
- +15 ;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.3644^5.3
- +16 ;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.4015^2.4
- +17 ;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^5.0445^9.9
- +18 ;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.5006^4.9
- +19 ;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.6740^2.8
- +20 ;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.2084^6.2
- +21 ;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.4820^2.3
- +22 ;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.1218^3.4
- +23 ;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7783^2.5
- +24 ;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5370^1.9
- +25 ;;834^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH MCC^6.0522^10.0
- +26 ;;835^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITH CC^2.1137^4.2
- +27 ;;836^17^MED^ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.1735^2.7
- +28 ;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^5.6993^11.5
- +29 ;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^2.2602^5.5
- +30 ;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.4872^4.4
- +31 ;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.2205^6.7
- +32 ;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.6216^4.0
- +33 ;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.0970^2.8
- +34 ;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.9076^5.3
- +35 ;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.1842^3.6
- +36 ;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8489^2.6
- +37 ;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.6729^5.9
- +38 ;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.3361^3.6
- +39 ;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.0323^3.0
- +40 ;;849^17^MED^RADIOTHERAPY^2.4936^6.2
- +41 ;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^4.9678^9.6
- +42 ;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^2.1222^5.3
- +43 ;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.5198^3.3
- +44 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.6639^9.2
- +45 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1024^5.4
- +46 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.3596^3.5
- +47 ;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.8967^5.0
- +48 ;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^1.0114^3.5
- +49 ;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8765^2.7
- +50 ;;865^18^MED^VIRAL ILLNESS WITH MCC^1.4778^3.9
- +51 ;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.8390^2.7
- +52 ;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.2371^5.5
- +53 ;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.0660^3.5
- +54 ;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.7285^2.5
- +55 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.4390^12.4
- +56 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.8722^4.8
- +57 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.0263^3.5
- +58 ;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.2680^7.0
- +59 ;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.8645^2.6
- +60 ;;881^19^MED^DEPRESSIVE NEUROSES^0.8020^3.9
- +61 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.8236^3.2
- +62 ;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.5818^5.1
- +63 ;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.4473^4.5
- +64 ;;885^19^MED^PSYCHOSES^1.2394^5.9
- +65 ;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^1.2237^4.3
- +66 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.0798^3.0
- +67 ;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.5490^2.0
- +68 ;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.5992^8.9
- +69 ;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7803^4.9
- +70 ;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8270^3.4
- +71 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.2687^8.8
- +72 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.9643^4.8
- +73 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.1353^2.6
- +74 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.7270^7.1
- +75 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.6500^3.3
- +76 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^1.8038^2.8
- +77 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.9482^6.8
- +78 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^2.0504^3.9
- +79 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.3710^2.4
- +80 ;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.6386^3.7
- +81 ;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.8869^2.5
- +82 ;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.6995^3.7
- +83 ;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.6584^1.8
- +84 ;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.4785^3.5
- +85 ;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.7916^2.3
- +86 ;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.8441^4.3
- +87 ;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0246^2.9
- +88 ;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.6979^2.1
- +89 ;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.5882^4.1
- +90 ;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^0.9398^2.7
- +91 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^21.0913^26.0
- +92 ;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^6.5316^11.7
- +93 ;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^3.0139^5.9
- +94 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^2.2629^2.4
- +95 ;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^1.9409^4.3
- +96 ;;935^22^MED^NON-EXTENSIVE BURNS^1.9329^3.6
- +97 ;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.3746^6.6
- +98 ;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.2209^3.5
- +99 ;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^1.9231^2.2
- +100 ;;945^23^MED^REHABILITATION WITH CC/MCC^1.4819^5.0
- +101 ;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.1262^3.2
- +102 ;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.1940^3.5
- +103 ;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.7871^2.6
- +104 ;;949^23^MED^AFTERCARE WITH CC/MCC^1.1099^4.3
- +105 ;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.7402^3.0
- +106 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.5596^1.8
- +107 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.2893^7.3
- +108 ;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.8500^6.0
- +109 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.4209^9.1
- +110 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.2057^6.7
- +111 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.7361^4.2
- +112 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7299^5.2
- +113 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.4918^3.9
- +114 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9125^2.6
- +115 ;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^5.8519^11.1
- +116 ;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^2.9887^6.6
- +117 ;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.6905^6.3
- +118 ;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.2821^4.0
- +119 ;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^0.9496^3.0
- +120 ;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.3243^3.6
- +121 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.6145^8.4
- +122 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.5366^4.6
- +123 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.6523^2.3
- +124 ;;987^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.2759^7.7
- +125 ;;988^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.7064^4.3
- +126 ;;989^99^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.1236^2.3
- +127 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0.0^0.0
- +128 ;;999^99^**^UNGROUPABLE^0.0^0.0
- +129 ;;EXIT